| scholarly article | Q13442814 |
| P50 | author | Marco Prinz | Q30055422 |
| Brian W. Simons | Q55381217 | ||
| Charles G Eberhart | Q87148391 | ||
| P2093 | author name string | Gabriele Niedermann | |
| Guido Nikkhah | |||
| Jörg Schubert | |||
| Jaroslaw Maciaczyk | |||
| Ulf D Kahlert | |||
| Thomas Brabletz | |||
| Brent A Orr | |||
| Tomasz Bogiel | |||
| Soroush Doostkam | |||
| Thomas Reithmeier | |||
| Donata Maciaczyk | |||
| P2860 | cites work | Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma | Q28286168 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 42-53 | |
| P577 | publication date | 2012-05-28 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition | |
| P478 | volume | 325 |
| Q92723391 | A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma |
| Q100415759 | A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma |
| Q36729416 | An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer |
| Q48487663 | Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients |
| Q49167080 | BAF53a is a potential prognostic biomarker and promotes invasion and epithelial-mesenchymal transition of glioma cells |
| Q36389768 | CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells |
| Q55052358 | CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma. |
| Q38091173 | Cancer stem cell contribution to glioblastoma invasiveness |
| Q93168989 | Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/β-catenin signaling pathway |
| Q41904013 | Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma |
| Q35176432 | Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells |
| Q38775522 | Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy |
| Q47152150 | Combination of AQP1 and β-catenin expression is an independent prognosis factor in astrocytoma patients |
| Q90035541 | Combining Ellagic Acid with Temozolomide Mediates the Cadherin Switch and Angiogenesis in a Glioblastoma Model |
| Q33786677 | Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity. |
| Q33945781 | Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme. |
| Q48148598 | Developmentally regulated signaling pathways in glioma invasion. |
| Q33792688 | Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition |
| Q38677439 | EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities. |
| Q48227731 | Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members |
| Q38719842 | Epithelial-mesenchymal transition in glioblastoma progression |
| Q46359599 | Expression Levels and Localizations of DVL3 and sFRP3 in Glioblastoma |
| Q36817102 | Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma. |
| Q39404706 | Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells |
| Q55116204 | FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma. |
| Q90179423 | Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma |
| Q49719103 | Glioma infiltration and extracellular matrix: key players and modulators. |
| Q49722615 | Homeobox B3 promotes tumor cell proliferation and invasion in glioblastoma |
| Q58583093 | Hypermethylation of Secreted Frizzled Related Protein 1 gene promoter in different astrocytoma grades |
| Q55347904 | Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro. |
| Q36231984 | Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition |
| Q47162378 | Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma |
| Q38780791 | Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis |
| Q58116685 | Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4 |
| Q35550219 | KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers |
| Q90446104 | Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1 |
| Q36808390 | MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation |
| Q38767738 | Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling |
| Q55059234 | Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure. |
| Q89883748 | Meg3 Induces EMT and Invasion of Glioma Cells via Autophagy |
| Q91859000 | Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas |
| Q36139783 | MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma |
| Q47183915 | Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles |
| Q92996626 | Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells |
| Q55457391 | Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas. |
| Q36915235 | Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling |
| Q38848185 | Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells |
| Q57153312 | Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma |
| Q38399161 | Prognostic significance of E-cadherin and N-cadherin expression in Gliomas |
| Q30552040 | Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis |
| Q48753389 | Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility |
| Q42317550 | Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells |
| Q36247757 | Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway |
| Q26765903 | Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype |
| Q48258004 | Signaling pathways and mesenchymal transition in pediatric high-grade glioma. |
| Q91668935 | Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway |
| Q38721639 | Silencing of Armadillo Repeat-Containing Protein 8 (ARMc8) Inhibits TGF-β-Induced EMT in Bladder Carcinoma UMUC3 Cells |
| Q47294523 | Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling |
| Q41451541 | Stem cell niches in glioblastoma: a neuropathological view |
| Q34645242 | Store-operated Ca(2+) entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation |
| Q37699420 | Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma |
| Q38744334 | TIPE2 Inhibits Hypoxia-Induced Wnt/β-Catenin Pathway Activation and EMT in Glioma Cells |
| Q38223161 | Taking advantage of neural development to treat glioblastoma |
| Q38951799 | The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation |
| Q38685226 | The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation |
| Q49804881 | The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor |
| Q60956374 | The STAT3/Slug Axis Enhances Radiation-Induced Tumor Invasion and Cancer Stem-like Properties in Radioresistant Glioblastoma |
| Q34644859 | The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer |
| Q37621027 | The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance |
| Q58748412 | The complement system in glioblastoma multiforme |
| Q46989668 | The expressions of Wnt/β-catenin pathway-related components in brainstem gliomas. |
| Q41827259 | The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner |
| Q34154786 | Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms |
| Q33748280 | Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma |
| Q34205345 | Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin. |
| Q58114002 | Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation |
| Q38660744 | WNT signaling in glioblastoma and therapeutic opportunities |
| Q39214992 | Wnt signaling in triple-negative breast cancer. |
| Q35752332 | ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. |
| Q55458506 | ZEB1 expression in Chinese lower-grade gliomas. |
| Q33669366 | ZEB1 regulates glioma stemness through LIF repression |
| Q91714449 | ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance |
| Q27015111 | ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance |
| Q61808206 | ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway |
| Q57040103 | Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion |
| Q37746117 | miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients |
| Q92665337 | miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway |
| Q37089951 | sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line |
Search more.